Search
Antisense oligonucleotides are an emerging therapeutic option to treat diseases with known genetic origin. In the age of personalised medicines, antisense oligonucleotides can sometimes be designed to target and bypass or overcome a patient's genetic mutation, in particular those lesions that compromise normal pre-mRNA processing. Antisense oligonucleotides can alter gene expression through a variety of mechanisms as determined by the chemistry and antisense oligomer design.
An InFocus Research Interview with Kirsten Hancock of the Human Capability Team at The Kids Research Institute Australia on multigenerational disadvantage in Australia.
Professor Bloom used his time to make a powerful case for the idea that 'healthier means wealthier' at the The Kids Annual Community Lecture for 2017
Curtin University researcher Belinda Cuomo is one of the first recipients of a CoLab Top-Up Scholarship.
New research has found children who are born even slightly premature or underweight are more likely to be hospitalised with an infection during their childhood
Anne MacKenzie has been recognised with the award of Member of the Order of Australia (AM).
While many university students spend their summer break enjoying a bit of downtime, Will Kermode spent his in a laboratory.
The Kids Research Institute Australia has welcomed the Federal Government's commitment to legislate the Medical Research Future Fund
Perth's The Kids Research Institute Australia has welcomed the passing of legislation to establish the Medical Research Future Fund (MRFF).
Tasmania's Child and Family Centres are having a positive impact on parent's use and experiences of services and supports for young children